Paratek Pharmaceuticals, Inc.
PRTK · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$63,566 | -$59,084 | -$96,541 | -$128,790 |
| Dep. & Amort. | $490 | $391 | $578 | -$1,292 |
| Deferred Tax | $0 | $0 | $1,059 | $0 |
| Stock-Based Comp. | $12,319 | $14,336 | $10,248 | $14,295 |
| Change in WC | -$20,791 | -$8,189 | -$20,286 | -$21,499 |
| Other Non-Cash | $5,407 | $4,273 | $1,518 | $3,241 |
| Operating Cash Flow | -$66,141 | -$48,273 | -$103,424 | -$134,045 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$36 | -$373 | -$376 | -$239 |
| Net Acquisitions | $0 | $0 | $0 | -$239 |
| Inv. Purchases | -$15,160 | -$15,117 | -$29,625 | -$102,207 |
| Inv. Sales/Matur. | $30,000 | $20,000 | $122,500 | $237,000 |
| Other Inv. Act. | $0 | $0 | $0 | $239 |
| Investing Cash Flow | $14,804 | $4,510 | $92,499 | $134,554 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $7,329 | $18,392 | $21,891 | $26,559 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $5,093 | $18,332 | $11,340 | $57,622 |
| Financing Cash Flow | $5,093 | $18,332 | $11,340 | $57,622 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$46,244 | -$25,431 | $415 | $58,131 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $80,617 | $106,048 | $105,633 | $47,502 |
| End Cash | $34,373 | $80,617 | $106,048 | $105,633 |
| Free Cash Flow | -$66,177 | -$48,646 | -$103,800 | -$134,284 |